Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studies
Microbiome · 20.01.2025 · 13 (1)
DOI: 10.1186/s40168-024-02002-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiome, online erschienen am 20.01.2025. Verfasst von Elena Rampanelli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Vascular Medicine, Amsterdam UMC, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Eubacteriales. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: The human gut microbiome strongly influences host metabolism by fermenting dietary components into metabolites that signal to the host. Our previous work has shown that Intestinimonas butyriciproducens is a prevalent commensal bacterium with the unique ability to convert dietary fructoselysine to butyrate, a well-known signaling molecule with proven health benefits. Dietary fructoselysine is an abundant Amadori product formed in foods during thermal treatment and is part of foods rich in dietary advanced glycation end products which have been associated with cardiometabolic disease. It is therefore of interest to investigate the causal role of this bacterium and fructoselysine metabolism in metabolic disorders. RESULTS: We assessed associations of I. butyriciproducens with metabolic risk biomarkers at both strain and functional levels using a human cohort characterized by fecal metagenomic analysis. We observed that the level of the bacterial strain as well as fructoselysine fermentation genes were negatively associated with BMI, triglycerides, HbA1c, and fasting insulin levels. We also investigated the fructoselysine degradation capacity within the Intestinimonas genus using a culture-dependent approach and found that I. butyriciproducens is a key player in the butyrogenic fructoselysine metabolism in the gut. To investigate the function of I. butyriciproducens in host metabolism, we used the diet-induced obesity mouse model to mimic the human metabolic syndrome. Oral supplementation with I. butyriciproducens counteracted body weight gain, hyperglycemia, and adiposity. In addition, within the inguinal white adipose tissue, bacterial administration reduced inflammation and promoted pathways involved in browning and insulin signaling. The observed effects may be partly attributable to the formation of the short-chain fatty acids butyrate from dietary fructoselysine, as butyrate plasma and cecal levels were significantly increased by the bacterial strain, thereby contributing to the systemic effects of the bacterial treatment. CONCLUSIONS: I. butyriciproducens ameliorates host metabolism in the context of obesity and may therefore be a good candidate for new microbiota-therapeutic approaches to prevent or treat metabolic diseases. Video Abstract.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Experimental Vascular Medicine, Amsterdam UMC, Amsterdam, the Netherlands.
- Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.
- Proteomics, Metabolomics & Mass Spectrometry Laboratory, Institute for the Animal Production System in the Mediterranean Environment, National Research Council, 80055, Portici (Naples), Italy.
- State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan Microbiome Center, and Human Phenome Institute, Fudan University, Shanghai, 200438, China.
- Caelus Pharmaceuticals, Amsterdam, the Netherlands.
- The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna Stråket 16, 41345, Gothenburg, Sweden.
Zitieren
APA
Rampanelli, E., Romp, N., Troise, A. D., Ananthasabesan, J., Wu, H., Gül, I. S., De Pascale, S., Scaloni, A., Bäckhed, F., Fogliano, V., Nieuwdorp, M., & Bui, T. P. N. (2025). Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studies. Microbiome, 13(1). https://doi.org/10.1186/s40168-024-02002-9
Vancouver
Rampanelli E, Romp N, Troise AD, Ananthasabesan J, Wu H, Gül IS, et al. Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studies. Microbiome. 2025;13(1). doi:10.1186/s40168-024-02002-9
BibTeX
@article{Rampanelli2025,
author = {Rampanelli, Elena and Romp, Nadia and Troise, Antonio Dario and Ananthasabesan, Jakshana and Wu, Hao and Gül, Ismail Sahin and De Pascale, Sabrina and Scaloni, Andrea and Bäckhed, Fredrik and Fogliano, Vincenzo and Nieuwdorp, Max and Bui, Thi Phuong Nam},
title = {Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studies},
journal = {Microbiome},
year = {2025},
volume = {13},
number = {1},
doi = {10.1186/s40168-024-02002-9}
}
EUVIMED